A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients

Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells

Cornelius Knabbe, Marc E. Lippman, Lalage M. Wakefield et al. · Cell · 1987 · 982 citations

Life Sciences, Cell Biology, Oncology +12

Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer Patients

Michaël Pollak, J. Costantino, Constantin Polychronakos et al. · JNCI Journal of the National Cancer Institute · 1990 · 262 citations

Medicine, Endocrinology, Oncology +10

Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone

Paolo Lissoni, Sandro Barni, Sofia Meregalli et al. · British Journal of Cancer · 1995 · 152 citations · Full text

Medicine, Endocrinology, Oncology +15

Pineal Melatonin, Its Fundamental Immunoregulatory Role in Aging and Cancer

Georges J. M. Maestroni, Ario Conti, Walter Pierpaoli · Annals of the New York Academy of Sciences · 1988 · 142 citations

Medicine, Cancer Biology, Immunology +14

Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.

Thomas H. Inge, Shelley K. Hoover, Sandra K. Barrett et al. · PubMed · 1992 · 128 citations

Life Sciences, Immunology, Oncology +17